• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Healthcare·004720.KS
Share

PharmGen Science, Inc. Stocks

₩ 3065Last Updated 21.08.2026

Issuer Rating

3/7
Performance

Favourable

Risk

Considerable

Recommendation

Sell

Market Cap

₩ 51.42M

₩ 3065
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PharmGen Science, Inc., originally founded in 1961 as Wooridul Pharmaceutical Limited, is a South Korean company primarily involved in the research, development, manufacturing, and distribution of pharmaceutical products. Based in Hwaseong, South Korea, the firm offers a diverse portfolio encompassing prescription medications, over-the-counter drugs, nutritional supplements, and cosmetic items. These are available in various forms, including tablets, hard capsules, granules, ointments, syrups, and suspensions.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is 'cheap' on EV/EBITDA, underv

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.08.2026 21:01

Anthropic to Strengthen Founders' Rights and Unitree's 460% Surge: Key Takeaways on the IPO by August 23

23.08.2026 18:01

Investors' Magical Thinking: The Power of Rituals, Superstitions, and Luck in the Stock Market

23.08.2026 15:01

"Stop Drawing Colorful Charts": How to Make Plans in an Era of Change

22.08.2026 16:01

What's Happening in Small-Cap Stocks: Curaleaf's Offering, a New GLP-1 Drug, and a Defense IPO

22.08.2026 13:01

U.S. national debt weighs on the market; top model joins a Kazakhstani AI company; Nasdaq to open at night

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026